KHAN, M.A. et al. 2026. QBD-DRIVEN DESIGN AND PHARMACOKINETIC PROFILING OF REMOGLIFLOZIN ETABONATE SUSTAINED-RELEASE MATRIX TABLETS FOR DIABETES MANAGEMENT. International Journal of Applied Pharmaceutics. 18, 1 (Jan. 2026), 389–400. DOI:https://doi.org/10.22159/ijap.2026v18i1.56445.